Immunomedics Highlights Clinical Pipeline for Solid Cancer, Lupus Therapy at R&D Day
April 23, 2014 at 12:31 PM EDT
Immunomedics, Inc. (Nasdaq: IMMU), a biopharmaceutical company focused on the development of monoclonal antibody-based products for the ...